bethanidine has been researched along with Tetralogy of Fallot in 1 studies
Bethanidine: A guanidinium antihypertensive agent that acts by blocking adrenergic transmission. The precise mode of action is not clear.
Tetralogy of Fallot: A combination of congenital heart defects consisting of four key features including VENTRICULAR SEPTAL DEFECTS; PULMONARY STENOSIS; RIGHT VENTRICULAR HYPERTROPHY; and a dextro-positioned AORTA. In this condition, blood from both ventricles (oxygen-rich and oxygen-poor) is pumped into the body often causing CYANOSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dunnigan, A | 1 |
| Pritzker, MR | 1 |
| Benditt, DG | 1 |
| Benson, DW | 1 |
1 other study available for bethanidine and Tetralogy of Fallot
| Article | Year |
|---|---|
Life threatening ventricular tachycardias in late survivors of surgically corrected tetralogy of Fallot.
Topics: Adult; Bethanidine; Electrocardiography; Exercise Test; Female; Humans; Male; Postoperative Complica | 1984 |